Fennec Pharmaceuticals (FENC) Total Current Liabilities (2010 - 2026)
Fennec Pharmaceuticals' (FENC) quarterly Total Current Liabilities came in at $10.5 million in Q4 2025, up 52.02% YoY from $6.9 million in Q4 2024, and up 7.16% on a QoQ basis from $9.8 million in Q3 2025.
Fennec Pharmaceuticals (FENC) Total Current Liabilities (2010 - 2026) Analysis & Trends
Fennec Pharmaceuticals (FENC) has 16 years of Total Current Liabilities data on file, last reported at $10.5 million in Q4 2025.
- Quarterly Total Current Liabilities rose 52.02% year-over-year to $10.5 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $10.5 million (up 52.02% YoY) and the FY2025 annual result came in at $10.5 million, up 52.02% from the prior year.
- Total Current Liabilities rose to $10.5 million in Q4 2025, from $9.8 million in the prior quarter.
- In the past five years, Total Current Liabilities ranged from a high of $10.5 million in Q4 2025 to a low of $848000.0 in Q2 2021.
- A 5-year average of $5.4 million and a median of $4.3 million in 2022 frame the typical range for Total Current Liabilities.
- Annual changes were most pronounced in 2021 — Total Current Liabilities plunged 73.42% — and 2022, when it jumped 258.14%.
- Tracing FENC's Total Current Liabilities over 5 years: stood at $1.7 million in 2021, then surged by 178.66% to $4.6 million in 2022, then surged by 63.88% to $7.6 million in 2023, then dropped by 8.39% to $6.9 million in 2024, then jumped by 52.02% to $10.5 million in 2025.
- The last three Total Current Liabilities figures came in at $10.5 million (Q4 2025), $9.8 million (Q3 2025), and $8.4 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 3.94 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 5.53 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.58 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 354.06 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 2.12 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 4.22 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 630.93 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.51 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 438.74 Mn |
| 10 | Fennec Pharmaceuticals | 410.60 Mn | 369.35 Mn | 17.15 Mn | 12.39 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 12.39 Mn |
| Dec 31, 2025 | 10.52 Mn |
| Sep 30, 2025 | 9.82 Mn |
| Jun 30, 2025 | 8.41 Mn |
| Mar 31, 2025 | 8.37 Mn |
| Dec 31, 2024 | 6.92 Mn |
| Sep 30, 2024 | 7.44 Mn |
| Jun 30, 2024 | 7.75 Mn |
| Mar 31, 2024 | 9.84 Mn |
| Dec 31, 2023 | 7.55 Mn |
| Sep 30, 2023 | 3.91 Mn |
| Jun 30, 2023 | 3.78 Mn |
| Mar 31, 2023 | 4.02 Mn |
| Dec 31, 2022 | 4.61 Mn |
| Sep 30, 2022 | 2.93 Mn |
| Jun 30, 2022 | 3.04 Mn |
| Mar 31, 2022 | 2.14 Mn |
| Dec 31, 2021 | 1.65 Mn |
| Sep 30, 2021 | 2.01 Mn |
| Jun 30, 2021 | 848,000.00 |